IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?

Key Takeaways IDEXX Laboratories' stock jump is tied to strong CAG Diagnostics recurring revenue momentum. IDXX's CAG recurring revenues grew over 10% organically, with gains in the U.S. and international regions. High demand for cloud-based products and expanding Vello adoption further boosted IDEXX Laboratories' growth. IDEXX Laboratories (IDXX) has shown remarkable momentum so far this year, climbing 75.6%. The stock outperformed the industry’s 4.2% rise and the S&P 500 composite’s 18.5% gain.Carrying a ...